SCHEMBL19769698

SCHEMBL19769698

CCn1c2ccccc2c2c(C)c(C)c3c4ccccc4n(Cc4ccccc4)c3c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.54
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
MAPK1 P28482 3/20 0.49
P2RX4 Q99571 2/20 0.49
ALDH1A1 P00352 5/20 0.45
KDM4E B2RXH2 4/20 0.45
TDP1 Q9NUW8 3/20 0.45
HSD17B10 Q99714 2/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
UTS2R Q9UKP6 1/20 0.43
MAPT P10636 3/20 0.42
MCL1 Q07820 1/20 0.42
TNF P01375 1/20 0.42
NSD2 O96028 1/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19769696 0.94 CYP19A1 (0.54) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19769699 0.93 CYP19A1 (0.50) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19769916 0.91 CYP19A1 (0.54) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL25491302 0.89 ALDH1A1 (0.53) MEN1KMT2AMAPK1ALDH1A1KDM4E
SCHEMBL19799316 0.87 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL17445354 0.84 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL19829059 0.82 ALDH1A1 (0.50) MEN1KMT2AMAPK1ALDH1A1KDM4E
SCHEMBL19799320 0.81 CYP19A1 (0.50) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1
SCHEMBL25491299 0.81 ALDH1A1 (0.49) MEN1KMT2AMAPK1ALDH1A1KDM4E
SCHEMBL19799321 0.81 CYP19A1 (0.53) CYP19A1SMN1; SMN2MEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180019409-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2018-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180019409-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE AND ORGANIC OPTOELECTRONIC DEVICE AND DISPLAY DEVICE OR10J3, OR51E2, OXER1 CYP19A1 577/4885SMN1; SMN2 4206/4885MEN1 2498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.